Tobacco use is the cause of several urologic cancers. Persistent use after diagnosis is associated with worse cancer-specific, quality of life, and overall mortality outcomes. Cigarette smoking remains the most common form of tobacco use despite significant population-level decline over the past few decades. The burden of smoking-related urologic disease is under appreciated by urologists and patients which has resulted in gaps in clinical care and limitations to research progress. We sought to summarize evidence-based practices and guideline recommendations for assessing and reporting tobacco use in the clinical and research settings. With a focus on smoking, our two primary goals are: 1) to promote the adoption of standardized and validated measures of tobacco use and 2) to highlight evidence-based strategies for urologists to use in clinical practice.

烟草使用是导致多种泌尿系统癌症的原因。诊断后持续使用与更差的癌症特异性、生活质量和总体死亡率结果相关。尽管过去几十年人口水平显着下降，但吸烟仍然是最常见的烟草使用形式。泌尿科医师和患者对吸烟相关泌尿系统疾病的负担认识不足，这导致了临床护理的差距和研究进展的限制。我们试图总结在临床和研究环境中评估和报告烟草使用的循证实践和指南建议。专注于吸烟，我们的两个主要目标是：